Amyloidosis secondary to familial Mediterranean fever: machine learning-based prediction models

Berkay Aktas1, Enes Azman1, Yusuf Ecren Oner1

  • 1Division of Rheumatology, Internal Medicine Department, Cerrahpasa Faculty of Medicine, Istanbul-University Cerrahpasa, Istanbul, Türkiye.

Abstract

Insights

Machine learning models can predict amyloidosis, a severe complication of Familial Mediterranean Fever (FMF). Ensemble methods like random forest show promise for early risk identification in FMF patients.

Area of Science:

  • Genetics and Precision Medicine
  • Autoinflammatory Diseases
  • Machine Learning in Healthcare

Background:

  • Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disorder.
  • Amyloidosis is the most severe complication of FMF, leading to significant morbidity.
  • Predicting amyloidosis risk is crucial for timely intervention in FMF patients.

Purpose of the Study:

  • To compare the predictive performance of logistic regression, random forest, and gradient boosting models for amyloidosis in FMF patients.
  • To identify key clinical and genetic factors associated with amyloidosis development in FMF.

Main Methods:

  • Retrospective analysis of 615 FMF patients diagnosed between 1990 and 2022.
  • Extraction of clinical, genetic, and laboratory data.
  • Development and evaluation of logistic regression, random forest, and gradient boosting models using hyperparameter tuning and a held-out test set.

Main Results:

  • Amyloidosis was present in 9.4% of patients, associated with earlier onset, male sex, M694V homozygosity, comorbidities, and specific clinical features.
  • Multivariate analysis identified disease duration, M694V homozygosity, comorbidity, parental consanguinity, frequent infections, and erysipelas-like erythema as independent predictors.
  • Random forest model demonstrated the highest predictive performance (ROC-AUC = 0.784), outperforming logistic regression and gradient boosting.

Conclusions:

  • Amyloidosis in FMF is influenced by a combination of clinical and genetic factors.
  • Ensemble machine learning models, particularly random forest, offer superior early risk prediction for amyloidosis compared to traditional logistic regression.
  • Identifying high-risk FMF patients enables proactive management to prevent severe complications like amyloidosis.